Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.60+0.14 (+1.34%)
Close on Nov 17, 2026Market cap $891.37MP/E 13.8Yield –
Bioventus operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Bioventus's operating income for the twelve months ending Jun 27, 2026 was $58.28M, up 68.5% year over year. For fiscal 2025 it was $53.98M. The highest annual figure on record is $53.98M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.98M | – |
| FY2024 | Dec 31, 2024 | -$15.20M | – |
| FY2023 | Dec 31, 2023 | -$81.73M | – |
| FY2022 | Dec 31, 2022 | -$167.23M | -1486.6% |
| FY2021 | Dec 31, 2021 | $12.06M | -43.2% |
| FY2020 | Dec 31, 2020 | $21.24M | -31.9% |
| FY2019 | Dec 31, 2019 | $31.19M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | $19.13M | +4.1% |
| Q1 FY2026 | Mar 28, 2026 | $8.42M | +72.8% |
| Q4 FY2025 | Dec 31, 2025 | $19.49M | +153.0% |
| Q3 FY2025 | Sep 27, 2025 | $11.25M | +208.5% |
| Q2 FY2025 | Jun 28, 2025 | $18.37M | – |
| Q1 FY2025 | Mar 29, 2025 | $4.87M | -1.2% |
| Q4 FY2024 | Dec 31, 2024 | $7.70M | +561.2% |
| Q3 FY2024 | Sep 28, 2024 | $3.65M | +50.8% |
| Q2 FY2024 | Jun 29, 2024 | -$31.47M | -566.3% |
| Q1 FY2024 | Mar 30, 2024 | $4.93M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.17M | – |
| Q3 FY2023 | Sep 30, 2023 | $2.42M | – |
| Q2 FY2023 | Jul 1, 2023 | $6.75M | – |
| Q1 FY2023 | Apr 1, 2023 | -$92.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.64M | – |
| Q3 FY2022 | Oct 1, 2022 | -$126.84M | – |
| Q2 FY2022 | Jul 2, 2022 | -$3.31M | – |
| Q1 FY2022 | Apr 2, 2022 | -$21.45M | -197.5% |
| Q4 FY2021 | Dec 31, 2021 | -$3.15M | -153.3% |
| Q3 FY2021 | Oct 2, 2021 | -$1.05M | -115.1% |
| Q2 FY2021 | Jul 3, 2021 | -$5.74M | – |
| Q1 FY2021 | Apr 3, 2021 | $22.00M | +69.4% |
| Q4 FY2020 | Dec 31, 2020 | $5.91M | – |
| Q3 FY2020 | Sep 26, 2020 | $6.93M | – |
| Q2 FY2020 | Jun 27, 2020 | -$4.59M | – |
| Q1 FY2020 | Mar 28, 2020 | $12.99M | – |
See a number that looks wrong?